Sainan Li
Hangzhou, 310014, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Lonidamine ameliorates MASH by reducing SREBP1 and inhibiting the MAPK pathway.
Journal: Acta biochimica et biophysica Sinica
Published: March 06, 2026
Performance and comparison of FLCCheck: a novel serum free light chain assay for the Auxiliary Diagnosis of Multiple Myeloma.
Journal: European journal of medical research
Published: April 02, 2025
Protein lipoylation in cancer: metabolic reprogramming and therapeutic potential.
Journal: Cell death discovery
Published: March 01, 2025
Targeting epigenetic and post-translational modifications of NRF2: key regulatory factors in disease treatment.
Journal: Cell death discovery
Published: January 14, 2025
Spatial distribution of the proteome in the human body and in cancers.
Journal: Nature
Published: November 23, 2024
Molecular signatures of disulfidptosis: interplay with programmed cell death pathways and therapeutic implications in oncology.
Journal: Cellular & molecular biology letters
Published: October 29, 2024
Ferroptosis mechanisms and its novel potential therapeutic targets for DLBCL.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 31, 2023
Multitissue Circadian Proteome Atlas of WT and Per1-/-/Per2-/- Mice.
Journal: Molecular & cellular proteomics : MCP
Published: April 27, 2023
High-Throughput and In-Depth Proteomic Profiling of 5 μL Plasma and Serum Using TMTpro 16-Plex.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: February 13, 2023
A pathway activity-based proteomic classifier stratifies prostate tumors into two subtypes.
Journal: Clinical proteomics
Published: January 26, 2023
Last Updated: 09/26/2026